SPON2 and gastric cancer: Studies of small numbers of patients with GC show that overexpression of SPON2 is associated with poor prognosis, although the underlying mechanisms and their effects on GC cells are unknown.18 Therefore, the current study employed a larger number of patients to answer these questions.